Blaize Stock Falls 12% on Short Seller Fraud Claims
businesssuntimes.com · post 63205 · 2026-07-11
NEW YORK, July 11 — A securities class-action investigation into Blaize Holdings, Inc. has been opened by the Rosen Law Firm, according to a July 9 announcement, following a sharp drop in the company’s stock price tied to fraud allegations from a short seller. The record shows that on April 28, 2026, shares of Blaize Holdings (NASDAQ: BZAI) fell 12 percent.
The decline came after Investing.com published an article titled “Blaize stock tumbles on short seller fraud allegations,” which reported that short seller Pelican Way Research had issued a report claiming the company’s recent $50 million deal with NeoTensr is fraudulent. That single-day market decline represents a significant loss in shareholder value, according to the Rosen Law Firm’s statement.
The firm is investigating whether Blaize issued materially misleading business information to the investing public. On the timeline, the sequence is clear. Pelican Way Research’s report triggered the Investing.com article on April 28.
The stock fell that same day. More than two months later, on July 9, the Rosen Law Firm announced its investigation.
Blaize Holdings has not issued a public response to the Pelican Way Research allegations, according to available records.
The Allegations and the Deal
At the center of the investigation is the $50 million deal between Blaize and NeoTensr. Pelican Way Research alleged that this transaction is fraudulent, according to the Investing.com report. Blaize Holdings, a technology company listed on the Nasdaq, had announced the NeoTensr deal prior to the short seller’s report.
The Rosen Law Firm, a national investor rights law firm, is focusing its investigation on whether Blaize made false or misleading statements to investors regarding its business operations and financial prospects.
Market Impact and Investor Concerns
The 12 percent decline on April 28 erased a substantial portion of Blaize’s market capitalization in a single trading session. For investors who purchased shares before the Pelican Way Research report, the losses were immediate. The investigation announced July 9 seeks to determine if company executives knew about potential problems with the NeoTensr deal before the short seller’s allegations became public.
The Rosen Law Firm has set a deadline for investors to come forward with information. The firm is asking shareholders who purchased Blaize securities to contact them regarding potential lead plaintiff status in any future class action.
Blaize Holdings has not yet filed any response with the Securities and Exchange Commission addressing the Pelican Way Research allegations, according to public filings reviewed by InfoPulse Today. The Nasdaq listing requires Blaize to disclose any material events that could affect shareholder value.